Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.China Pharma Holdings, a specialty pharmaceutical company, has appointed Frank Waung as its new CFO. In addition, the company has nominated Heung Tsui to the board of directors.
Subscribe to our email newsletter
Most recently, Mr Waung was a managing director at the boutique investment-banking firm, Hickey Friehofner Capital. Prior to that, he was a special situation analyst at DellaCamera Capital Management.
Ms Tsui is a self-employed businesswoman engaged in international trade and investments. Ms Tsui has graduated from Hunan Financial & Economic College.
China Pharma Holdings (CPHI) has also reported that Xihua Wu, who served as CFO and a director to CPHI since 2005 has resigned as CFO and as director of the board for personal reasons.
Zhilin Li, president and CEO of China Pharma, said: “We welcome Heung Tsui to join the board, and we look forward to her future contributions as we execute our growth plan. We also are pleased to welcome Mr Waung to our company and we hope that his professional background and industry experience will add value to CPHI’s future endeavors.”